BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1415 related articles for article (PubMed ID: 18549169)

  • 1. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histological significance of atypical glandular cell on Pap smear.
    Behtash N; Nazari Z; Fakhrejahani F; Khafaf A; Azar EG
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):46-9. PubMed ID: 17261100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Precancerous cervical lesions during pregnancy: diagnostic and treatment].
    Selleret L; Mathevet P
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S131-8. PubMed ID: 18191339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
    Costa MJ; Kenny MB; Naib ZM
    Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isthmic-vaginal smear cytology in the follow-up after radical vaginal trachelectomy for early stage cervical cancer: is it safe?
    Lanowska M; Mangler M; Grittner U; Akbar GR; Speiser D; von Tucher E; Köhler C; Schneider A; Kühn W
    Cancer Cytopathol; 2014 May; 122(5):349-58. PubMed ID: 24478265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocervical adenocarcinoma in situ. A histological entity to know].
    Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical and vaginal cytologic smears suggestive of adenocarcinoma.
    Pretorius R; Binstock M; Sadeghi M; Hodges W
    J Reprod Med; 1996 Jul; 41(7):478-82. PubMed ID: 8829059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology.
    Zweizig S; Noller K; Reale F; Collis S; Resseguie L
    Gynecol Oncol; 1997 May; 65(2):314-8. PubMed ID: 9159344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
    Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
    Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colposcopic management of abnormal cervical cytology in pregnancy.
    LaPolla JP; O'Neill C; Wetrich D
    J Reprod Med; 1988 Mar; 33(3):301-6. PubMed ID: 3361522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
    Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
    Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.